Literature DB >> 1111894

Hyperglycemia-induced hyponatremia: metabolic considerations in calculation of serum sodium depression.

J M Roscoe, M L Halperin, F S Rolleston, M B Goldstein.   

Abstract

Hyperglycemia is associated with a decrease in serum sodium concentration. Previous methods of estimating the degree of decrease have not considered the fact that glucose will enter certain cells despite relative insulin deficiency; thus, glucose will not contribute directly to the osmotic gradient responsible for water shifts into or out of these tissues. The expected decrease in serum sodium concentration is 1.35 meg/l for every 100mg/dl increase in blood glucose concentration - the metabolic correction factor. Although the numerical difference between this factor and that calculated by others is small, the metabolic implications could be critical. In the hyperglycemic state the water content of tissues not requiring insulin for glucose transport could increase, and where tissue swelling is physically restricted (for example, in the brain) this expansion could seriously affect organ function.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1111894      PMCID: PMC1956157     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  2 in total

1.  Hyperglycemia-induced hyponatremia--calculation of expected serum sodium depression.

Authors:  M A Katz
Journal:  N Engl J Med       Date:  1973-10-18       Impact factor: 91.245

2.  Fat absorption: a transport problem.

Authors:  C A Hogben
Journal:  Gastroenterology       Date:  1966-01       Impact factor: 22.682

  2 in total
  9 in total

1.  Hyperglycemia-induced hyponatremia.

Authors:  A H Tzamaloukas
Journal:  Can Med Assoc J       Date:  1976-12-18       Impact factor: 8.262

2.  An improved method to compute the solute and water derangements of hyperglycaemia.

Authors:  Ettore Bartoli; Luca Bergamasco; Pier Paolo Sainaghi; Francesca Guidetti; Luigi Castello
Journal:  Eur J Appl Physiol       Date:  2007-10-02       Impact factor: 3.078

3.  The variable hyponatremic response to hyperglycemia.

Authors:  S M Moran; R L Jamison
Journal:  West J Med       Date:  1985-01

Review 4.  Importance of timing of risk factors for cerebral oedema during therapy for diabetic ketoacidosis.

Authors:  A P C P Carlotti; D Bohn; M L Halperin
Journal:  Arch Dis Child       Date:  2003-02       Impact factor: 3.791

5.  A clinical approach to common electrolyte problems. 1. Hyponatremia.

Authors:  R A Bear; G A Neil
Journal:  Can Med Assoc J       Date:  1983-05-15       Impact factor: 8.262

Review 6.  Dialysis-associated hyperglycemia: manifestations and treatment.

Authors:  Yijuan Sun; Maria-Eleni Roumelioti; Kavitha Ganta; Robert H Glew; James Gibb; Darlene Vigil; Catherine Do; Karen S Servilla; Brent Wagner; Jonathan Owen; Mark Rohrscheib; Richard I Dorin; Glen H Murata; Antonios H Tzamaloukas
Journal:  Int Urol Nephrol       Date:  2020-01-18       Impact factor: 2.370

7.  Serum electrolyte levels in relation to macrovascular complications in Chinese patients with diabetes mellitus.

Authors:  Shenqi Wang; Xuhong Hou; Yu Liu; Huijuan Lu; Li Wei; Yuqian Bao; Weiping Jia
Journal:  Cardiovasc Diabetol       Date:  2013-10-10       Impact factor: 9.951

8.  The Corrected Serum Sodium Concentration in Hyperglycemic Crises: Computation and Clinical Applications.

Authors:  Todd S Ing; Kavitha Ganta; Gautam Bhave; Susie Q Lew; Emmanuel I Agaba; Christos Argyropoulos; Antonios H Tzamaloukas
Journal:  Front Med (Lausanne)       Date:  2020-08-25

Review 9.  Serum Sodium Concentration and Tonicity in Hyperglycemic Crises: Major Influences and Treatment Implications.

Authors:  Antonios H Tzamaloukas; Zeid J Khitan; Robert H Glew; Maria-Eleni Roumelioti; Helbert Rondon-Berrios; Moses S Elisaf; Dominic S Raj; Jonathan Owen; Yijuan Sun; Kostas C Siamopoulos; Mark Rohrscheib; Todd S Ing; Glen H Murata; Joseph I Shapiro; Deepak Malhotra
Journal:  J Am Heart Assoc       Date:  2019-09-24       Impact factor: 5.501

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.